招聘

我们是谁

  • 4 月 15, 2025
    EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial – 1)
  • 3 月 28, 2025
    Cadonilimab (AK104) Combined With Chemotherapy and Bevacizumab as First-line Treatment for RAS Mutated or Right Sided-metastatic MSS Colorectal Cancer
  • 2 月 25, 2025
    Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1，Chemotherapy and Target Therapy for Metastatic Colorectal Cancer
  • 2 月 24, 2025
    SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases
  • 2 月 24, 2025
    A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
  • 10 月 15, 2024
    Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
  • 10 月 14, 2024
    A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer
  • 8 月 23, 2024
    A Dose Escalation Study of AV-380 in Metastatic Cancer Patients With Cachexia
  • 7 月 29, 2024
    A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
  • 7 月 29, 2024
    MAQ-001 in Patients With Advanced Solid Tumors